BioPharma Drug Discovery

Biocytogen and LiberoThera Achieve Milestone Progress in Co-Development of Fully Human GPCR Antibody Drugs

In around a year since the collaboration was established, the two parties have screened out a number of fully human therapeutic antibody clones with excell...

 July 25, 2022 | News

China CDE Grants Breakthrough Therapy Designation (BTD) to Neurophth's NR082 in LHON

NR082 (rAAV2-ND4), a recombinant adeno-associated viral vector, serotype 2, containing human ND4 codon-optimized gene under the control of the cy...

 July 18, 2022 | News

Triastek & Lilly to explore the application of 3D printing technology in oral delivery of drugs

According to the agreement, the project will focus on the targeted release of drugs in the intestine. Triastek will focus on two aspects: Firstly, conduct ...

 July 14, 2022 | News

Sobi to license loncastuximab tesirine from ADC Therapeutics

Sobi® announced an exclusive license agreement with ADC Therapeutics SA to develop and commercialise loncastuximab tesirine for use in haematology and ...

 July 11, 2022 | News

Brii Biosciences Announces Commercial Launch of its Amubarvimab/Romlusevimab Combination Therapy for COVID-19 in China

Brii Bio progressed the combination therapy from discovery to global Phase 3 data readout  and first regulatory approval by the China NMPA in les...

 July 07, 2022 | News

EditForce and Mitsubishi Tanabe Pharma Enter into License Agreement

In this alliance, MTPC and EditForce aim to create potential novel pharmaceuticals for the specific CNS disease by utilizing the drug R&D know-how and ...

 July 06, 2022 | News

Eurofins Discovery Announces Acquisition of DiscoveryBioMed

Eurofins Discovery acquired DiscoveryBioMed for its expertise in leveraging primary and immortalized human diseased and normal cells to develop novel, cust...

 July 06, 2022 | News

Antengene Announces Clinical Trial Collaboration with BeiGene

Selinexor is an oral small molecule XPO1 inhibitor; tislelizumab is an anti-PD-1 checkpoint inhibitor Antengene Corporation Limited ("...

 June 27, 2022 | News

Menarini Group and Radius Health Submit New Drug Application to the U.S. FDA for Elacestrant

Intended for potential treatment of ER+/HER2- advanced or metastatic breast cancer patients Priority Review requested; if accepted, anticipate an 8-mont...

 June 23, 2022 | News

DIA and CoRE Gathering Key Healthcare Experts in Neutral Forum to Discuss Regulatory News and Drug Development

The COVID-19 pandemic has ushered an increased speed of healthcare innovations with the hope of effectively managing this public health threat. This meetin...

 June 16, 2022 | News

Ainnocence Launches Self-Evolving, Multi-Objective AI Drug Discovery Platform

#BIO2022  Ainnocence, a global biotech startup on a mission to accelerate drug discovery using a fast, self-evolving AI drug design platform, launche...

 June 14, 2022 | News

META raised 15M USD to accelerate its pipeline development

META Pharmaceuticals, China's first immunometabolism-based small-molecule drug discovery company, announced two consecutive Seed and Pre-A fundin...

 June 14, 2022 | News

Transdermal patches: the next frontier in global healthcare

This may come as a surprise, but transdermal and topical technology has been in existence long before injections, and pills became the norm. Ancient histor...

 June 10, 2022 | News

iNtRON Completes GLP-TOX Studies of BAL200

iNtRON Biotechnology ("iNtRON" or "Company") announced today that the company has successfully completed the GLP toxicology studies of BAL200. The company...

 June 07, 2022 | News


News

Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close